Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Reyranella

ABSTRACT: Reyranella sp. overview

PROVIDER: PRJNA687801 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	SRR13291549_1.fastq.gz	Fastqsanger.gz
	SRR13291549_2.fastq.gz	Fastqsanger.gz
	SRR15143039.fastq.gz	Fastqsanger.gz

Items per page:

1 - 4 of 4

Similar Datasets

Reyranella massiliensis

Project description:Reyranella massiliensis overview

| PRJNA169586 | ENA

Reyranella sp. OAS946

Project description:Reyranella sp. OAS946 Genome sequencing

| PRJNA580632 | ENA

Reyranella massiliensis

Project description:Reyranella massiliensis genome sequence

| PRJEB111 | ENA

Reyranella sp. CPCC 100927

Project description:Reyranella sp. CPCC 100927 Genome sequencing and assembly

| PRJNA557159 | ENA

Reyranella soli strain:NBRC 108950

Project description:Reyranella soli NBRC 108950 genome sequencing project

| PRJDB6325 | ENA

Reyranella aquatilis strain:KCTC 52223

Project description:Reyranella aquatilis strain:KCTC 52223 Genome sequencing and assembly

| PRJNA774366 | ENA

Genome sequence of Reyranella massiliensis, a bacterium associated with amoebae.

Project description:Reyranella massiliensis is an Alphaproteobacterium member of the class Rhodospirillaceae, growing in amoebae. We sequenced the genome of type strain 521(T). It is composed of a 5,792,218-bp chromosome and encodes 5,675 protein-coding genes and 53 RNA genes, including 3 rRNA genes.

| S-EPMC3458673 | biostudies-literature

Project description:Reyranella and Paenarthrobacter genomes

| PRJNA738185 | ENA

Transcriptomic and epigenetic dissection of spinal ependymoma (SP-EPN) identifies clinically relevant subtypes enriched for tumors with and without NF2 mutations [Methylation]

Project description:Background: Ependymomas encompass multiple, clinically relevant tumor types based on localization and molecular profiles. Although tumors of the methylation class “spinal ependymoma” (SP-EPN) represent the most common intramedullary neoplasms in children and adults, their developmental origin is ill-defined, molecular data are scarce, and the potential heterogeneity within SP-EPN remains unexplored. The only known recurrent genetic events in SP-EPN are loss of chromosome 22q and NF2 mutations, but neither types and frequency of these alterations nor their clinical meaning have been described in a large, epigenetically defined series. Methods: We mapped SP-EPN transcriptomes (n=76) to developmental atlases of the developing and adult spinal cord to uncover potential developmental origins of these tumors. In addition, transcriptomic, epigenetic (n=234), genetic (n=140), and clinical analyses (n=115) were integrated for a detailed overview on this entity. Results: Integration of transcriptomic ependymoma data with single-cell atlases of the spinal cord identified mature adult ependymal cells to display highest similarities to SP-EPN. Unsupervised hierarchical clustering of tumor data together with integrated analysis of methylation profiles identified two molecular SP-EPN subtypes. Subtype 1 predominantly contained NF2 wild type sequences with regular NF2 expression but revealed more extensive copy number alterations. Subtype 2 harbored previously known germline or sporadic NF2 mutations and was NF2-deficient in most cases, more often showed multilocular disease, and demonstrated a significantly reduced progression-free survival. Conclusion: Based on integrated molecular profiling of a large tumor series we identify two distinct SP-EPN subtypes with important implications for genetic counseling, patient surveillance, and drug development priorities.

2024-01-26 | GSE242991 | GEO